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Phorboid 20-homovanillates induce apoptosis through a
VR1-independent mechanism
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Background: Vanilloids, such as capsaicin and resiniferatoxin (RTX), are
recognized at the cell surface by vanilloid receptor type 1(VR1), which has
recently been cloned. VR1 mediates the effects of capsaicin and RTX in
VR1-expressing cells, but vanilloids can induce apoptosis through a pathway
not mediated by VR1. Phorbol 20-homovanillates can be used to investigate
cell death induced by vanilloids.
Results: 12,13-Diacylphorbol-20 homovanillates were prepared by the
sequential esterification of the natural polyol. Phorbol 12-phenylacetate
13-acetate 20-homovanillate (PPAHV) induced apoptosis in Jurkat cells to the
same extent as RTX. Apoptosis was preceded by an increase in intracellular
reactive oxygen species and by the loss of mitochondria transmembrane
potential. PPAHV-induced apoptosis was mediated by a pathway involving
caspase-3 activation and was initiated at the S phase of the cell cycle.
The cell-death pathway triggered by VR1 activation was studied in 293T cells
transfected with the cloned rat vanilloid receptor. In this system, capsaicin and
PPAHV induced cell death by an apparent necrotic mechanism, which was
selectively inhibited by the competitive vanilloid receptor antagonist
capsazepine. Interestingly, phorbol-12,13-bisnonanoate-20-homovanillate,
an analogue of PPAHV, induced cell death in VR1-transfected cells but could
not trigger apoptosis in the Jurkat cell line.
Conclusions: Vanilloids can induce cell death through different signalling
pathways. The cell death induced in a VR1-independent manner has the
hallmark of apoptosis, whereas the cell death mediated by vanilloids binding
to VR1 is seemingly necrotic. Phorboid homovanillates that have antitumour
and anti-inflammatory activities but lack the undesirable side effects of the
natural vanilloids could be developed as potential drugs. 
Introduction
Capsaicin (8-methyl-N-vanillyl-6-nonenamide, CPS),
which is responsible for the pungency of hot pepper, and
resiniferatoxin (RTX), a complex diterpenoid isolated
from certain succulent African Euphorbias, are considered
the archetypal vanilloids. These compounds interact at
specific membrane recognition sites (vanilloid receptors)
expressed almost exclusively by primary sensory neurons
involved in nociception and neurogenic inflammation [1],
and in tracheobronchial tissues [2,3].
It is generally accepted that specific vanilloid receptors
mediate the effects of CPS and RTX in some cell systems.
Thus, transient exposure of nociceptor terminals to cap-
saicin leads to excitation and desensitisation in dorsal root
ganglion neurons and to an increase in intracellular
calcium [4–6]. These biological activities underlie the use
of capsaicin as an analgesic agent in the treatment of
painful disorders such as peripheral neuropathies and
rheumatoid arthritis [7–9]. The recent cloning of a vanil-
loid receptor, termed VR1 (vanilloid receptor subtype 1),
has shown that this receptor belongs to the family of puta-
tive store/operate calcium channels and it is expressed
exclusively in trigeminal dorsal root sensory ganglia [6].
VR1 also is a receptor for the endogenous cannabinoid
anandamide [10].
In addition to having these biological activities, CPS is an
inhibitory quinone analogue that can inhibit NADH
oxidase found in plasma membranes [11], and can induce
apoptosis by a vanilloid-receptor-independent pathway in
transformed cells and in activated T cells [12–14]. We
have shown recently that CPS-induced apoptosis in trans-
formed cells was preceded by an increase in reactive
oxygen species (ROS) and subsequent disruption of the
mitochondrial transmembrane potential (∆Ψm), a process
that can be related to mitochondrial permeability transi-
tion pore opening (PT), as PT inhibitors (such as Bcl-2
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and cyclosporine A) inhibit this disruption [13,14]. Fur-
thermore, CPS has also been shown to have immunomod-
ulatory effects, as indicated by its ability to modulate
lymphocyte proliferation and immunoglobulin production
[15–17], and to induce interleukin-4 (IL-4) production by
mast cells [18]. Taken together, these results indicate that
CPS, and perhaps other vanilloids, have pleiotropic activi-
ties, presumably mediated by the activation of cellular
targets other than VR1, which can be expressed not only
in sensory neurons but also in other cell types [11].
In the past decade, the information obtained on the exis-
tence of different subtypes of receptors came mainly from
two sources: binding experiments using [3H]RTX, an
ultrapotent CPS analogue, and capsazepine, a competitive
CPS antagonist [9]; and through the use of CPS analogues
such as phorbol 12-phenylacetate 13-acetate 20-
homovanillate (PPHAV), which binds to the CPS receptor
in a non-cooperative manner on sensory neurons. Unlike
CPS, however, in different biological assays, it is not
pungent topically and does not result in hypothermia
when injected in animal models [19,20]. Szallasi et al.
[21,22] have shown that cloned VR1 mediates both the R-
type binding and the C-type calcium response in dorsal
root ganglion neurons. Moreover, it has been shown that
phorboid-20 homovanillates are useful for evaluating struc-
ture–activity relations at the vanilloid receptor in both rat
trigeminal ganglion neuron [23] and in other types of cells
transfected with the gene encoding VR1 [24]. Surprisingly,
the effects of these phorbol–RTX hybrids on non-neu-
ronal cells have not been investigated to date.
Here, we show that the vanillyl moiety of CPS, RTX and
PPAHV is required to produce intracellular ROS genera-
tion, to open the mitochondria megachannels (called per-
meability transition, PT), and to induce apoptosis in
human transformed cell lines that do not express VR1. We
also show that PPAHV-induced apoptosis is mediated via
a pathway that involves caspase-3 and occurs at the spe-
cific cell-cycle checkpoint that controls G1–S phase transi-
tion. The cell death mediated through VR1 was studied in
293T cells transfected with the cloned rat vanilloid recep-
tor. This form of cell death induced by both CPS and
PPAHV could be inhibited by the competitive vanilloid
receptor antagonist capsazepine. In contrast to RTX and
CPS, PPAHV also activates the transcription factor AP-1,
at least in part via the mutogen-activated protein kinase
signalling pathway. Nevertheless, PPAHV-mediated
apoptosis does not require AP-1 activation and is not
affected by MAPK inhibition. Possible mechanisms by
which natural and phorbol-derived vanilloids can induce
apoptosis or necrosis are also discussed.
Results
The capacity of different vanilloid analogues to induce
apoptosis in human transformed cell lines has been inves-
tigated. The compounds used in this study are shown in
Figure 1: 1, CPS; 2, RTX; 3, phorbol 12-phenylacetate
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Figure 1
Chemical structures of 1, CPS, 2, RTX, 3,
PPA, 4, PPAHV, 5, DPAHV and 6, PBNHV.



































































1 2
3 4
5 6
Chemistry & Biology
13-acetate (PPA); 4, PPAHV; 5, 12-dehydrophorbol
13-acetate 20-homovanillate (DPAHV); and 6, phorbol-12,
13-bisnonanoate-20-homovanillate (PBNHV).
Induction of apoptosis by capsaicin and vanilloids
analogues in Jurkat cells
It is now accepted that a breakdown in ∆Ψm and the gen-
eration of ROS are invariant features of early apoptosis
[25–30]. Thus, we studied the role of ∆Ψm and ROS gen-
eration in the apoptotic pathway induced in Jurkat T cells
by the following compounds: CPS (200 µM), RTX
(10 µM); ROPA (aresinferol o-phenylacetate, a 20-decy-
lated derivative of RTX) (10 µM), DPAHV (10 µM),
PPAHV (10 µM), PBNHV (10 µM) and PPA (10 µM) in
the presence of vanillate (10 µM). The cells were treated
for 6 h, and ROS generation and ∆Ψm dissipation were
detected by double staining experiments, using
hydroethidine (HE; nonfluorescent), which becomes
ethidium (Eth; red fluorescent) after its oxidation via
ROS, and DiOC
6
(3) (green fluorescent), a cationic probe
that accumulates in mitochondria as a function of its
potential [31]. After treatment for 18 h, hypodiploidy (i.e.,
loss of fragmented DNA) was analysed, using propidium
iodide (PI) staining, as a marker for apoptosis.
In these experiments, untreated cells were taken as con-
trols, with a high ∆Ψm (DiOC6(3)
high) and low levels of
intracellular ROS (HE→Eth)low (Figure 2). As expected,
CPS and RTX induced an increase in the percentages of
DiOC
6
(3)low/(HE→Eth)high and DiOC
6
(3)high/(HE→Eth)high
cells, whereas the percentage of DiOC
6
(3)low/(HE→Eth)low
cells did not change, when compared with untreated cells.
The role of the vanillyl moiety of these hybrid molecules
in this apoptotic pathway was demonstrated by the finding
that PPAHV was as efficient as RTX at inducing first ROS
generation, and then ∆Ψm disruption and apoptosis in
Jurkat cells, whereas neither PPA in the presence of vanil-
late nor DPAHV affected these parameters. DPAHV is a
hybrid molecule with a nonactive phorbol moiety [19].
Moreover, ROPA was ineffective at inducing ROS gener-
ation and apoptosis in this cell line. Together, these
results show that the vanillyl moiety of these compounds
is responsible for the biological effects measured in our
model, but the other moiety of the molecule (alkyl in
CPS or diteperne in RTX and PPAHV) is also required
(Figure 2a). Apoptosis was also measured using the
TUNEL method (see the Materials and methods section
for details), and we found that both RTX and PPAHV
induced apoptosis in Jurkat cells in a dose-dependent
manner, with similar relative potencies. Interestingly,
PBNHV, which contains an active phorbol moiety, did
not induce a significant level of apoptosis in the Jurkat
cell line (Figure 2a,b). The low levels of apoptosis found
with the higher doses of ROPA and PBNHV is not medi-
ated by an increase in intracellular ROS and it is not sta-
tistically significant.
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Chemistry & Biology
Induction of apoptosis by vanilloids in Jurkat cells. (a) Jurkat cells were
treated with CPS (200 µM), RTX (10 µM), ROPA (10 µM), PPAHV
(10 µM), PBNHV (10 µM), PPA (10 µM) plus vanillate (10 µM), and
DPAHV (10 µM). After a 6 h treatment, half of the cells were collected
and the simultaneous ∆Ψm disruption and ROS generation detected
using cytofluorimetry. The results represent the percentage of cells
obtained in biparametric histograms delimited by four compartments:
∆Ψmhigh (normal cells, bottom right compartment); ∆Ψmlow (bottom left);
(HE→Eth)high (ROS-generating cells, top right), and
(HE→Eth)high/∆Ψmlow (pre-apoptotic cells, top left compartment).
Apoptosis was measured after 18 h of treatment by cell-cycle analysis
with PI staining (percentage of apoptotic cells between brackets).
Results are representative of five independent experiments.
(b) Detection of DNA strand breaks using the TUNEL method. Jurkat
cells were treated with increasing concentrations of the indicated
compounds for 18 h and the percentage of apoptotic cells determined.
Values are means ± SD of three independent experiments.
Apoptosis induced by PPAHV in Jurkat cells is mediated
by caspase-3 activation and occurs at the S phase of the
cell cycle
The caspase family comprises post-aspartate-cleaving cys-
teine proteases that have been shown to be required for
apoptosis in a number of experimental systems [32–34].
To establish the involvement of caspases in PPAHV-
mediated apoptosis of Jurkat cells, we pre-incubated cells
with the tetrapeptide caspase inhibitors acetyl-DEVD-
cmk (cmk, chloromethylketone) or Z-YVAD-cmk before
PPHAV treatment. Z-YVAD-cmk, which was reported to
specifically inhibit caspase-1 and related enzymes, had
little effect on the increase in the percentage of subdiploid
cells induced by PPAHV (at 20 µM). In contrast, the same
doses of acetyl-DEVD-cmk, which is more specific for the
inhibition of caspase-3, a member of the CED-3 subfamily
of caspases, abolished the apoptosis induced by PPAHV.
Nevertheless, PPAHV-treated cells died even when
caspase-dependent DNA loss was blocked (Figure 3a).
This caspase-independent death has been termed necro-
sis, and it is also triggered after the loss of ∆Ψm [30,33,35],
suggesting that intracellular ROS induced by PPHAV and
other vanilloids can be a signal that regulates both necrotic
and apoptotic cell death.
The involvement of cell cycle control in apoptosis
induced by PPAHV and RTX in Jurkat cells was studied
by double staining with PI and FITC–dUTP, as described
in the Materials and methods section. This method
allowed us to determine in which phase of the cell cycle
DNA fragmentation occurs. Thus, in Figure 3b we show
that most of the DNA fragmentation was detected in S
phase in Jurkat cells treated for 18 h with either PPAHV
or RTX (both at 20 µM). We also detected, however, a
small but significant percentage of cells that undergo
DNA fragmentation at Go/G1 phase when treated with
both homovanillates.
Cell death induced by phorboid 20-homovanillates in
VR1-transfected 293T cells
It has been shown that CPS induces cell death in 293T
cells transfected with rat VR1. This cell death occurs
486 Chemistry & Biology 2000, Vol 7 No 7
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(a) The caspase-3 inhibitor Ac-DEVD-cmk inhibits PPAHV-induced
apoptosis. Jurkat cells were treated with PPHAV (20 µM) in the
presence or absence of the caspase inhibitors acetyl-DEVD-cmk
(100 µM) and Z-YVAD-cmk (100 µM) for 18 h, and the percentage of
subdiploid cells was detected using flow cytometry. Cell death was also
determined by PI staining as described in the Materials and methods
section. (b) S-phase dependency for apoptosis induced by PPAHV and
RTX. Jurkat cells were stimulated with PPAHV and RTX (both at 20 µM)
for 18 h and the cell cycle and the DNA strand breaks analysed using
flow cytometry. Results are representative of three separate experiments.
rapidly and with a concentration of CPS that does not
induce apoptosis in the absence of VR1 [6,13]. To evalu-
ate the role of VR1 in the cell death induced by synthetic
vanilloids in 293T cells, we co-transfected the cells either
with an expression plasmid containing the entire VR1
cDNA or with the empty vector (pcDNA3), and with an
equimolar concentration of the plasmid pEGFP-C1. The
cells were stimulated, 48 h after transfection, with CPS
(3 µM) for 6 h, and the percentage of green fluorescent
cells was detected using flow cytometry. We found that
this cell type is transiently transfected with high effi-
ciency; Figure 4a illustrates that more than 50% of the
cells express the green fluorescent protein. The percent-
age of positive cells did not change with CPS treatment in
the pcDNA3 co-transfected cells, whereas a clear reduc-
tion in this percentage was observed in cells co-trans-
fected with the plasmid pcDNA3-VR1. 
We also found that PPAHV (1 µM) was as effective as
CPS in the induction of cell death in VR1-transfected
293T cells. The cell death induced by both vanilloids was
completely inhibited in the presence of capsazepine
(10 µM), a competitive CPS antagonist (Figure 4b). Inter-
estingly, the phorbol homovanillate PBNHV, which binds
VR1 and has an active phorbol moiety [24], induces cell
death in the VR1-transfected 293T cells at 1 µM
(Figure 4b), but did not induce ROS generation or ∆Ψm
disruption at doses up to 10 µM in either Jurkat or 293T
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Figure 4
Capzasepine inhibits PPAHV and capsaicin-
induced cell death in VR1-transfected cells.
(a) Capsaicin induced cell death in VR1-
transfected 293T cells. The cells were co-
transfected with the plasmid pEGFP-C1 and
either pcDNA-3 or pcDNA3-VR1 plasmids.
After 48 h, the cells were stimulated with CPS
(3 µM) for 6 h and the adherent live cells
analysed for the expression of the green
fluorescent protein by cytometry. Results are
representative of five seperate experiments.
(b) 293T cells were co-transfected with the
pEGFP-C1 and pcDNA-VR1 plasmids and
48 h after transfection the cells were
stimulated for 6 h with the indicated
compounds. The percentage of green
fluorescent cells was analyzed as described
above. Values are means ± SD of three
independent experiments.
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cells (Figure 2a and data not shown). Altogether, these
results indicate that vanilloids may induce cell death by at
least two mechanisms: the first is mainly mediated by
apoptosis and occurs in transformed cells that do not
express the vanilloids receptor type I; the second, which
requires lower doses of vanilloids, is effective in
VR1-expressing cells and is likely to be mediated by a
rapid necrotic pathway.
Phorboid 20-homovanillates induce AP-1 activation in
transformed cells
The activity of the transcription factor AP-1 is regulated
by de novo synthesis of Jun and Fos, as well as by post-
transcriptional modification of c-Jun through phosphoryla-
tion of its transactivation domain [36–38]. 
Members of the MAPK family [38,39] mediate the regula-
tion of AP-1 in response to external stimuli. The best
characterized MAPKs are the extracellular signal-regu-
lated protein kinases 1 and 2 (ERK 1 and 2) and the c-Jun
amino-terminal kinases (JNK; also known as stress-acti-
vated protein kinase, SAPK). As ERK1 and 2 and JNK can
be activated by phorbol esters [40–43], we studied the
possible activation of the AP-1 transcription factor in
Jurkat and in HeLa cells stimulated with different phor-
boid 20-homovanillate hybrids molecules. 
Nuclear extracts from phorbol myristate acetate (PMA)-
treated Jurkat cells exhibited a strong binding to an end-
labelled AP-1 probe (Figure 5a). Anti-Jun and anti-Fos
antiserum were used in cold competition assays leading to
a supershift, further demonstrating the specificity of this
binding (data not shown). A similar increase in AP-1–DNA
binding was detected in Jurkat cells after 3 h of treatment
with PPAHV (10 µM), PBNHV (10 µM) and PPA
(10 µM), demonstrating that coupling of the homovanil-
late group to PPA did not interfere with its ability to acti-
vate AP-1. Moreover, we did not detect a clear increase in
the binding of AP-1 to DNA in the nuclear extracts from
RTX-stimulated cells (Figure 5a).
In order to correlate these results with transcriptional
activities, HeLa cells were transiently transfected with a
luciferase reporter construct under the control of three
AP-1 binding sites. Cells were treated, 24 h after transfec-
tion, for a further 24 h with increasing concentrations of
RTX, DPAHV, PPA, PPAHV and PBNHV separately,
and the luciferase activity was measured. Both PPA and
PBNHV, which, at the doses tested, induce neither ROS
generation nor apoptosis, increased AP-1-dependent tran-
scription up to tenfold induction over the basal levels
(Figure 5b). By contrast, neither RTX nor DPAHV (which
is inactive as a phorbol ester) was able to activate gene
transactivation driven by AP-1. It is interesting to note
that PPAHV activated AP-1 transcription in a dose-depen-
dent manner, peaked at 10 µM, and then decreased with
doses of 20 and 40 µM, when ROS generation and apopto-
sis are already detected (Figure 2a,b).
ROS generation and disruption of ∆Ψm induced by PPAHV
is independent of AP-1 activation and is not protected by
ERK1/2 activation
The role of AP-1 activation in the apoptotic pathways acti-
vated by different stimuli is not yet clear [13,44–47].
Moreover, activation of protein kinase C (PKC) can
induce, via the c-Raf pathway, the activation of the MAPK
ERK1/2 [48], which, in some models, prevents apoptosis
and promotes cell survival [49–51]. As we found that
PPHAV induced AP-1 activation and apoptosis, we
studied whether or not AP-1 had a role in the apoptotic
pathway induced by this phorboid homovanillate. To
address this question, we preincubated Jurkat cells with
the ERK inhibitor PD98059 (50 µM). The cells were then
stimulated with PPHAV (20 µM) for 2 h to detect AP-1
binding and for 6 h to study ROS generation and ∆Ψm dis-
ruption. Figure 6a illustrates that both PMA and PPAHV
induced AP-1 binding to DNA, and that the ERK
inhibitor prevented the binding of AP-1 to DNA almost
completely in cells activated by PPAHV. 
On the contrary, the same doses of the inhibitor did not
prevent the biochemical mechanisms leading to apopto-
sis in PPAHV-treated cells, that is PD98059 alone did
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Figure 5
Induction of AP-1 activation by phorboid 20-homovanillates.
(a) Nuclear extracts were prepared from Jurkat cells treated with PMA
(50 ng/ml), PPAHV (10 µM), RTX (10 µM), PPA (10 µM) and PBNHV
(10 µM) for 3 h, and then analyzed for AP-1 binding by EMSA.
(b) HeLa cells were transiently transfected with an AP-1-dependent
luciferase reporter construct and 24 h later stimulated with different
concentrations of the agonists indicated. After 24 h stimulation, the
cells were lysed and the luciferase activity measured. The
transcriptional activity was expressed as x-fold transactivation over the
values obtained with non stimulated cells. Values are means ± SD of
three independent experiments.
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not induce any changes in the levels of intracellular ROS
and did not affect the mitochondria transmembrane
potential (Figure 6b).
Discussion
Natural products can provide important leads to develop
new drugs and to discover the specific cellular targets
underlying their activities. Pungent vanilloids have been
shown to act through VR1 [6], but there is mounting evi-
dence that their effects are not exclusively mediated by
this temperature-sensitive cation channel. To further
explore this issue, natural or synthetic vanilloids lacking
pungent activity and/or VR1-binding capacity and screen-
ing assays that can differentiate between VR1-dependent
and VR1-independent biological actions are needed.
Here, we show that cell-death pathways induced by vanil-
loids are biochemically different, depending on the
expression or lack of VR1. We have developed two differ-
ent, rapid screening systems that allowed us to conclude
that vanilloid-induced cell death in non-VR1-expressing
cells has the hallmark of apoptosis, whereas a necrotic
pathway mediates cell death in VR1-transfected cells.
We have found that different but structurally related
vanilloids (natural and synthetic) can induce apoptosis in
tumour cells by a VR1-independent pathway. The mol-
ecular basis of this activity seems to be a specific inter-
action of vanilloids with the plasma membrane redox
system (PMOR), which is upregulated in transformed and
in activated peripheral T cells [11,14]. This interaction
may result in the inhibition of NADH oxidase enzymatic
activity, for which oxygen is the terminal electron accep-
tor. Our results are consistent with the concept that CPS
and RTX interfere with the CoQ-binding site of the
NADH oxidase system, leading to the redirection of
normal electron flow in the complex, thereby generating
an excess of ROS that eventually activates the apoptotic
pathway [11–14,52,53]. In contrast, in VR1-transfected
cells the cell death induced by vanilloids occurs rapidly
and is not preceded by an increase in ROS generation
before the disruption of ∆Ψm (data not shown). Moreover,
the concentrations of vanilloids required for killing VR1-
expressing cells are at least tenfold lower for phorboid
homovanillates and 100-fold lower for CPS than the doses
required for induction of apoptosis in transformed cells
that do not express this receptor.
In the apoptotic pathway induced independently of VR1
expression, the vanillyl moiety of natural and synthetic
vanilloids is responsible for the induction of cell death; the
proper delivery of the vanillyl moiety to cells by the rest of
the molecule is, however, also important. Accordingly, Jung
et al. [54] have shown recently that CPS binds to the intra-
cellular domain of VR1. These results do not exclude the
possibility that other vanilloids can interact with the extra-
cellular domain of this receptor. Nevertheless, they demon-
strate that vanilloids can be taken up by cells and exert
their function on the inner side of the plasma membrane. 
The results obtained with phorboid 20-homovanillates
demonstrate that the phorbol template can magnify vanil-
loid activity. Apoptosis induced by PPAHV is, however,
independent of AP-1 activation, because PPA, a compound
that does not induce ROS, was as potent as PPAHV in acti-
vating AP-1. Moreover, the ERK inhibitor PD98059 inhib-
ited AP-1 binding to DNA, but did not inhibit ROS
generation or the mitochondrial function in PPAHV-
treated Jurkat cells. In addition, DPAHV, another phor-
boid-20-homovanillate that is not active as a phorbol ester,
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Figure 6
Induction of ROS by PPAHV in Jurkat cells is
independent of AP-1 DNA binding activity.
(a) PD98059 (50 µM) inhibits the AP-1
binding in the nuclear extracts of Jurkat cells
stimulated for 3 h with PPAHV. (b) PD98059
(50 µM) does not affect either ROS
generation or ∆Ψm dissipation in
PPAHV-treated cells for 6 h.
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did not activate AP-1; neither did it induce ROS nor apop-
tosis. This is consistent with the fact that PKC is a cytosolic
enzyme that, upon activation, is translocated to the inner
side of the cell surface, where it can phosphorylate multiple
substrates [55,56]. In this context, the vanilloid moiety of
the molecule could interact with the PMOR system,
inhibiting the NADH oxidase activity and generating ROS. 
The binding sites for the alkyl moiety of CPS and the
diterpene core of RTX are not well characterized. Further-
more, it has recently been shown that RTX, but not CPS,
binds a kinase distinct from the PKC isotypes α, β, γ, δ and
ε [57]. This result is in agreement with our finding that
RTX did not activate AP-1. In phorbol–RTX hybrids, the
esterification pattern of the cyclohexane ring is important
for the induction of ROS and apoptosis in transformed
cells. Thus, the phorboid homovanillate PBNHV, a com-
pound which is able to activate AP-1 binding to DNA and
AP-1-dependent transactivation but which is unable to
induce ROS generation, could nevertheless induce cell
death in VR1-expressing cells. This finding implies differ-
ences between the effects of vanilloids on VR1 and the
inhibition of the PMOR system. A possible explanation is
that the large lipophilic moiety of PBNHV renders the
PMOR system inaccessible to the vanilloid moiety.
Capsaicin has been used topically as an analgesic for a long
time, but the systemic use of vanilloids is limited by their
neurotoxicity and their capacity to induce neurogenic
inflammation [1]. Upon activation, CPS-sensitive nerves
transmit signals to the central nervous system and release
pro-inflammatory neuropeptides such as substance P and
calcitonin-gene-related peptide into the periphery [58,59].
These neuropeptides can induce mast cells degranulation
with the consequent release of proteoglycans, histamine
and serotonine, and cytokines such as interleukins and
tumour necrosis factor-α [60,61]. Thus, the identification
of natural or synthetic vanilloids endowed with apoptotic
activities but unable to bind and activate the VR1 may be
of special interest to design new antitumour and anti-
inflammatory drugs.
Significance
Vanilloids are a class of structurally diverse compounds
exemplified by capsaicin (CPS) and resiniferatoxin
(RTX). In the past two decades, these compounds have
been extensively investigated for their analgesic potential
in the treatment of painful disorders, a biological effect
that is seemingly mediated by the activation of the vanil-
loid receptor type I (VR1), a heat-sensitive ion channel
expressed mainly in nociceptive neurons. We and others
have shown that CPS and RTX can induce apoptosis in
transformed cells that do not express VR1. In this report,
we demonstrate that vanilloid-induced apoptosis occurs
mainly at the S phase of the cell cycle and is mediated by
a caspase-3-dependent mechanism. In contrast, cell death
induced by vanilloids through VR1 activation is mediated
by a necrotic mechanism that can be clearly differentiated
from the apoptotic pathway. Employing complementary
methods to screen the apoptotic properties of vanilloids,
we discovered that, despite having a much reduced affin-
ity for VR1, certain phorboid homovanillates can induce
apoptosis with the same potency as the ultrapotent vanil-
loid RTX. These compounds therefore represent interest-
ing leads for the development of new anticancer drugs.
Materials and methods
Cell lines and reagents
Jurkat cells (ATCC, Rockville, MD, USA) were maintained in exponen-
tial growth in RPMI-1640 medium (Bio-Whittaker, VerViers, Belgium),
and the human embryonic kidney-derived 293T cells and the cervix
cancer HeLa cells (ATCC) in DMEM (Bio-Whittaker). The culture
media were supplemented with 10% heat-inactivated foetal calf serum,
2 mM L-glutamine and the antibiotics penicillin and streptomycin
(Gibco, Paisley, Scotland). [γ-32P]ATP (3000 Ci/mmol) was purchased
from ICN (Costa Mesa, CA, USA). Capsazepine and resiniferonol
(ROPA) was purchased from Alexis Co (Läufelfingen, Switzerland). The
cell-permeable inhibitors of caspase-1 (Z-YVAD-cmk), and caspase-3
(acetyl-DEVD-cmk) were obtained from Bachem (Switzerland). FITC-
12-deoxy-2-uridine triphosphate (FITC-dUTP) and terminal deoxynu-
cleotidetransferase (TdT) were obtained from Boehringer Mannheim
(Germany). The ERK inhibitor PD98059, was from Calbiochem (La
Jolla, CA, USA). All other reagents not cited above or later were
obtained from Sigma Chemical Co. (Barcelona, Spain).
Synthesis of phorboid 20-homovanillates
Synthesis of PBNHV as representative: phorbol was reacted with a
large excess (12 mol. equiv.) of nonanoyl chloride (pyridine, room tem-
perature [RT], 24 h, 75%). The 12,13,20-triester was then transesteri-
fied with 0.001 N HClO4 in methanol (RT, 24 h, 89%), and the
resulting 12,13-diester was esterified with MEM2-Methoxyethoxy-
methyl-homovanillic acid (DCC, dicyclohexylcarbodiimide DMAP
4-dimethylaminopyridine, and CH2Cl2, 90%). The MEM group was
finally removed with SnCl4 in THF [tetrahydrofuran] (4 mol. equiv, RT,
4 h, 71%), PPA (phorbol 12-phenylacetic 13-acetate), DPAHV
(12-dehydrophorbol 13-acetate 20- homovanillate) and PPAHV
(Phorbol 12-phenylacetate 13-acetate 20-homovanillate) were synthe-
sized as previously reported [19].
Determination of mitochondrial transmembrane potential and
ROS generation
To study the mitochondrial transmembrane potential and ROS genera-
tion, we incubated the cells (106/ml) in phosphate-buffered saline
(PBS) with DiOC6(3) (green fluorescence) (20 nM) (Molecular Probes
Europe) and dihydroethidine (HE) (red fluorescent after oxidation)
(2 µM) (Sigma) for 20 min at 37°C, followed by analysis on an Epics
XL Analyzer (Coulter, Hialeah, FL, USA). Where indicated, the per-
centage of live cells and those that had undergone death was deter-
mined by incubating an aliquot of the cells with 10 µg/ml of PI for
2 min at RT. Cells permeable to PI (i.e., dead) appear as red fluores-
cence by flow cytometry.
Determination of nuclear DNA loss and cell cycle analysis
The percentage of cells undergoing chromatinolysis (subdiploid cells)
was determined by ethanol fixation (70%, for 24 h at 4°C). Then, the
cells were washed twice with PBS containing 4% glucose and sub-
jected to RNA digestion (using RNAse-A, 50 U/ml) and PI (20 µg/ml)
staining in PBS for 1 h at RT. The cell cycle was analyzed by cytofluo-
rimetry as previously described [62]. With this method, low molecular
weight DNA leaks from the ethanol-fixed apoptotic cells and the subse-
quent staining allows determination of the percentage of subdiploid
cells (the sub-G0/G1 fraction).
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Detection of DNA strand breaks using the TUNEL method
The percentage of apoptotic cells was also measured using the TUNEL
method, as previously described [63], with minor modifications. Briefly,
cells (1 × 106) were fixed in 4% paraformaldehyde in PBS for 24 h at
4°C, washed twice in PBS and permeabilized in 0.1% sodium citrate
containing 0.1% Triton X-100 for 2 min Fixed cells were washed three
times in PBS and resuspended in a final volume of 50 µl of TUNEL
buffer (0.3 nmol FITC-dUTP, 3 nmol dATP, 50 nmol CoCl2, 5 U TdT,
200 mM potassium cacodylate, 250 µg/ml bovine serum albumen
(BSA) and 25 mM Tris-HCl pH 6.6). The cells were incubated for 1 h at
37°C and then washed twice in PBS and analyzed by flow cytometry.
To determine both DNA strand breaks and the phase of the cell cycle
cells were in, TUNEL-stained cells were counterstained with PI and
treated with RNAse, as described above, prior to cytofluorimetric analy-
sis. In this method, fixation in formaldehyde prevents extraction of low
molecular weight DNA from apoptotic cells and thus the cell cycle dis-
tribution estimates both apoptotic and nonapoptotic cells [63].
Isolation of nuclear extracts and mobility shift assays
Jurkat cells were cultured at 2 × 106/ml and stimulated with the ago-
nists in complete medium, as indicated. Cells were then washed twice
with cold PBS and proteins from nuclear extracts isolated as previously
described [13]. Protein concentration was determined by the Bradford
method (Bio-Rad, Richmond, CA, USA). For the electrophoretic mobil-
ity shift assay (EMSA), a double-stranded oligonucleotide containing
the AP-1 site of the metallothioneine promoter was used. The binding
reaction mixture contained 3 µg of nuclear extract, 0.5 µg poly(dI-dC)
(Pharmacia Fine Chemical, Piscataway, NJ, USA), 20 mM HEPES
pH 7, 70 mM NaCl, 2 mM DTT, 0.01% NP-40, 100 µg/ml BSA, 4%
Ficoll, and 100 000 cpm of end-labelled DNA fragments in a total
volume of 20 µl. After a 20 min incubation at 4°C, the mixture was elec-
trophoresed through a native 6% polyacrylamide gel containing 89 mM
Tris-borate, 89 mM boric acid and 1 mM EDTA. Gels were pre-elec-
trophoresed for 30 min at 225 V and then for 2 h after loading the
samples. These gels were dried and exposed to XAR film at –70°C.
Transient transfections and luciferase activity
293T cells (105/ml) were transiently co-transfected with the pEGFP-C1
plasmid encoding a brighter fluorescent variant of the Green Fluores-
cence Protein (Clontech, Palo Alto, CA) and either the plasmid encod-
ing the complete rat cDNA VR1 [6] or the empty vector, pcDNA3
(Invitrogen, Leek, The Netherlands). The transfections were performed
using lipofectamine reagent (Life Technologies, Madrid, Spain), accord-
ing to the manufacturer’s recommendations. Forty eight hours after
transfection, the cells were stimulated with the different compounds for
6 h and the percentage of adherent green fluorescent cells (live cells)
measured by flow cytometry. To determine AP-1-dependent transcrip-
tion, HeLa cells were transfected with the AP-1-luciferase (0.5 µg/ml)
reporter plasmid that was constructed by inserting three copies of a
SV40 AP-1-binding site into the Xho site of pGL-2 promoter vector
(Promega Co., WI, USA). Twenty four hours post-transfection, the cells
were stimulated with the indicated agonists for 24 h and then lysed in
25 mM Tris-phosphate pH 7.8, 8 mM MgCl
2
, 1 mM dithiothreilol, 1%
Triton X-100, and 15% glycerol. Luciferase activity was measured in a
luminometer (Lumat Berthold, Bad Wildbad, Germany) following the
instructions of the luciferase assay kit (Promega Co.). The background
obtained with the lysis buffer was subtracted in each experimental value.
All the experiments were repeated at least three times.
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